Clinical Trial Update: Postmarketing Surveillance Study With MOBEC®

View source ↗

Summary

A postmarketing surveillance study of MOBEC® in osteoarthritis has completed, sponsored by Boehringer Ingelheim.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• MOBEC

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Osteoarthritis | Status: COMPLETED